Magnitude of Infection and Its Resistance to Rifampicin Using Xpert-MTB/RIF Assay Among Presumptive Tuberculosis Patients at Motta General Hospital, Northwest Ethiopia

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2021 Apr 15

PMID 33854346

Citations 8

Authors

Tesfaye Andualem Demissie

Dereje Belayneh

Affiliations

Soon will be listed here.

Abstract

Background: (MTB) and its drug resistance form are the devastating infectious diseases in the world. It is the major cause of morbidity and mortality in low-income countries with Ethiopia carrying a heavy burden. Data on the magnitude of MTB and rifampicin resistance using Xpert- MTB/RIF assay is limited in the study area. Therefore, this study aimed to assess the prevalence of and rifampicin resistance among presumptive TB patients using GeneXpert at Motta General Hospital, North West Ethiopia.

Methods: A retrospective cross-sectional study was conducted from 1st October to 30 November 2020 among patients tested for GeneXpert at Motta General Hospital, Northwest Ethiopia. Data recorded on GeneXpert test results were collected on laboratory registration book in Microbiology laboratory. Data were analyzed by using the Statistical Package for Social Sciences (SPSS) version 20.

Results: A total of 4109 specimens were tested using the GeneXpert automated system. Of these, the majority 2148 (52.3%) of participants were males and 1961 (47.7%) were females. Similarly, about 1553 (37.8%) were in the age range of 25-44 years followed by 1347 (32.8%) in 45-64 years. Moreover, about 2486 (60.5%) participants were from rural. The overall prevalence of was 346 (8.4%) among these, the majority 222 (5.4%) had unknown HIV status, 48 (1.2%) were HIV positive, and 314 (7.6%) was new MTB cases. The overall prevalence of rifampicin resistance was 15 (4.3%) and 8(1.7%) were intermediate. Among rifampicin resistance, 10 (2.9%) were males, 8(2.3%) lived in rural, 9 (2.6%) had unknown HIV status, 13 (3.8%) were new TB patients, and 13 (3.8%) had pulmonary tuberculosis.

Conclusion: The prevalence of was 8.4% and relatively higher rate of rifampicin-resistant was found.

Citing Articles

Prevalence of Pulmonary Tuberculosis and Rifampicin Resistance Among Patients Attending Adama Hospital Medical College.

Kumbi H, Abate A, Kedir A, Chala T, Gemechu M, Garedew A Int J Microbiol. 2025; 2025:1475396.

PMID: 39974279 PMC: 11839255. DOI: 10.1155/ijm/1475396.

Detection of Rifampicin Resistance rpoB Gene Using GeneXpert MTB/RIF Assay in Pulmonary Tuberculosis Cases at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia.

Sharew B, Berhan A, Almaw A, Erkihun M, Tiruneh T, Kiros T J Clin Lab Anal. 2024; 38(22):e25111.

PMID: 39387506 PMC: 11584306. DOI: 10.1002/jcla.25111.

Rifampicin Resistant Tuberculosis Among Presumptive Pulmonary Tuberculosis in Province Referral Hospital, Indonesia: Dynamic Cases of a 7-Year Report.

Maulina N, Hayati Z, Hasballah K, Zulkarnain Z, Waraztuty I, Defadheandra A J Res Health Sci. 2024; 24(1):e00601.

PMID: 39072537 PMC: 10999105. DOI: 10.34172/jrhs.2024.136.

Molecular detection of rifampicin-resistant by polymerase chain reaction in Ethiopia: a systematic review and meta-analysis.

Birhanu M, Bekele G, Jemberie S Front Med (Lausanne). 2024; 11:1319845.

PMID: 38912342 PMC: 11190194. DOI: 10.3389/fmed.2024.1319845.

Tuberculosis treatment outcomes and associated factors among tuberculosis patients treated at healthcare facilities of Motta Town, Northwest Ethiopia: a five-year retrospective study.

Limenh L, Kasahun A, Sendekie A, Seid A, Mitku M, Fenta E Sci Rep. 2024; 14(1):7695.

PMID: 38565912 PMC: 10987627. DOI: 10.1038/s41598-024-58080-0.

References

Yohanes A, Abera S, Ali S . Smear positive pulmonary tuberculosis among suspected patients attending metehara sugar factory hospital; eastern Ethiopia. Afr Health Sci. 2013; 12(3):325-30. PMC: 3557681. DOI: 10.4314/ahs.v12i3.12. View

Soini H, Vasankari T . [MDR tuberculosis]. Duodecim. 2014; 130(16):1599-605. View

Adejumo O, Daniel O, Otesanya A, Salisu-Olatunj S, Abdur-Razzaq H . Evaluation of outcomes of tuberculosis management in private for profit and private-not-for profit directly observed treatment short course facilities in Lagos State, Nigeria. Niger Med J. 2017; 58(1):44-49. PMC: 5715566. DOI: 10.4103/0300-1652.218417. View

Arega B, Menbere F, Getachew Y . Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis. 2019; 19(1):307. PMC: 6449910. DOI: 10.1186/s12879-019-3943-1. View

Zewdie O, Dabsu R, Kifle E, Befikadu D . Rifampicin-Resistant Multidrug-Resistant Tuberculosis Cases in Selected Hospitals in Western Oromia, Ethiopia: Cross-Sectional Retrospective Study. Infect Drug Resist. 2020; 13:3699-3705. PMC: 7585775. DOI: 10.2147/IDR.S274589. View

Bodena D, Ataro Z, Tesfa T . Trend Analysis And Seasonality Of Tuberculosis Among Patients At The Hiwot Fana Specialized University Hospital, Eastern Ethiopia: A Retrospective Study. Risk Manag Healthc Policy. 2019; 12:297-305. PMC: 6912008. DOI: 10.2147/RMHP.S228659. View

Seung K, Keshavjee S, Rich M . Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015; 5(9):a017863. PMC: 4561400. DOI: 10.1101/cshperspect.a017863. View

Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D . Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos Referral Hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017; 10(1):8. PMC: 5217448. DOI: 10.1186/s13104-016-2328-4. View

Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D . Diagnosis of tuberculosis and drug resistance: what can new tools bring us?. Int J Tuberc Lung Dis. 2012; 16(7):860-70. DOI: 10.5588/ijtld.12.0180. View

10.

Gebrehiwet G, Kahsay A, Welekidan L, Hagos A, Abay G, Hagos D . Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia. J Infect Dev Ctries. 2020; 13(1):21-27. DOI: 10.3855/jidc.10462. View

11.

Gebretsadik D, Ahmed N, Kebede E, Mohammed M, Belete M . Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia. Infect Drug Resist. 2020; 13:1507-1516. PMC: 7247715. DOI: 10.2147/IDR.S248059. View

12.

Zignol M, Dean A, Falzon D, Van Gemert W, Wright A, Van Deun A . Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance. N Engl J Med. 2016; 375(11):1081-9. DOI: 10.1056/NEJMsr1512438. View

13.

Dessalegn M, Daniel E, Behailu S, Wagnew M, Nyagero J . Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia. Pan Afr Med J. 2017; 25(Suppl 2):5. PMC: 5390063. DOI: 10.11604/pamj.supp.2016.25.2.9203. View

14.

Raviglione M . The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015. Bull World Health Organ. 2007; 85(5):327. PMC: 2636638. DOI: 10.2471/blt.06.038513. View

15.

Derseh D, Moges F, Tessema B . Smear positive pulmonary tuberculosis and associated risk factors among tuberculosis suspects attending spiritual holy water sites in Northwest Ethiopia. BMC Infect Dis. 2017; 17(1):100. PMC: 5270299. DOI: 10.1186/s12879-017-2211-5. View

16.

Sah S, Bhattarai P, Shrestha A, Dhami D, Guruwacharya D, Shrestha R . Rifampicin-resistant by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal. Infect Drug Resist. 2020; 13:2911-2919. PMC: 7445509. DOI: 10.2147/IDR.S263795. View

17.

Charambira K, Ade S, Harries A, Ncube R, Zishiri C, Sandy C . Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe. Public Health Action. 2016; 6(2):122-8. PMC: 4913675. DOI: 10.5588/pha.16.0005. View

18.

Ejeta E, Beyene G, Bonsa Z, Abebe G . Xpert MTB/RIF assay for the diagnosis of and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia. J Clin Tuberc Other Mycobact Dis. 2019; 12:14-20. PMC: 6830166. DOI: 10.1016/j.jctube.2018.06.002. View

19.

Adane K, Ameni G, Bekele S, Abebe M, Aseffa A . Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. BMC Public Health. 2015; 15:572. PMC: 4473837. DOI: 10.1186/s12889-015-1933-9. View

20.

Gelaw Y, Assefa Y, Soares Magalhaes R, Demissie M, Tadele W, Dhewantara P . TB and HIV Epidemiology and Collaborative Service: Evidence from Ethiopia, 2011-2015. HIV AIDS (Auckl). 2020; 12:839-847. PMC: 7721114. DOI: 10.2147/HIV.S284722. View